Cobalt has advised venture capital funds Creathor Venture and MedTech Innovation Partners on financing the Finnish startup Blueprint Genetics.
Cobalt describes Blueprint Genetics as "an internationally successful provider of clinical genetic testing for the diagnosis of inherited diseases."
The start-up will receive a total of up to EUR 14 million from the financing round, which was led by new investors, with existing investors Inventure and Pontos Group participating as well.
The Cobalt team included Partner Kristel Raidla-Talur and Associates Greete-Kristiine Kuru, Jesse Kivisaari, Aleksander Tsuiman, and Liina Saaremets.
